Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic Parkinsonism. Part 1: Eradication of Helicobacter in the Cachexia of Idiopathic Parkinsonism

作者: R. John Dobbs , Sylvia M. Dobbs , Clive Weller , Ingua T. Bjarnason , Norman L. Oxlade

DOI: 10.1111/J.1523-5378.2005.00331.X

关键词:

摘要: Background.  Links between etiology/pathogenesis of neuropsychiatric disease and infection are increasingly recognized. Aim.  Proof-of-principle that contributes to idiopathic parkinsonism. Methods.  Randomized, double-blind, placebo-controlled efficacy study proven Helicobacter pylori eradication on the time course facets parkinsonism. Intervention was 1 week's triple therapy/placebos. Routine deblinding at 1 year (those still infected received open-active), with follow-up 5 years post-eradication. Primary outcome mean stride length free-walking speed, sample size 56 for a difference, active vs. placebo, 3/4 (between-subject standard deviation). Recruitment subjects parkinsonism H. pylori stopped 31, because marked deterioration failure. Interim analysis made in 20 who had reached deblinding, seven whom were receiving antiparkinsonian medication (long-t1/2, evenly spaced) which remained unchanged. Results.  Improvement stride-length, (n = 9) placebo (11), exceeded effect calculated when analyzed intention-to-treat basis (p = .02), protocol six weekly assessments, including (p = .02) excluding (p = .05) those medication. Active (blind or open) failed 4/20, B-lymphocyte count lower. Their was: −243 (95% CI −427, −60) 45 (−10, 100) mm/year remainder (p = .001); ratio, torque extend flex relaxed arm, 349 (146, 718) 58 (27, 96)%/ year (p < .001); independently rated, visual-analog scale stance–walk videos (worst–best per individual ≡ 0–100 mm), −64 −3 mm from anterior −50 11 lateral (p = .004 .02). Conclusions.  points direct surrogate (not necessarily unique) role particular pathogenesis With failure, bolus release antigen killed bacteria could aggravate an ongoing infection.

参考文章(32)
R. J. Hughes, R. S. Struthers, A. M. Fong, P. A. Insel, Regulation of the atrial natriuretic peptide receptor on a smooth muscle cell. American Journal of Physiology-cell Physiology. ,vol. 253, ,(1987) , 10.1152/AJPCELL.1987.253.6.C809
J Robin Warren, Barry Marshall, UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS The Lancet. ,vol. 321, pp. 1273- 1275 ,(1983) , 10.1016/S0140-6736(83)92719-8
Shing-Shing Yeh, Michael W Schuster, Geriatric cachexia: the role of cytokines The American Journal of Clinical Nutrition. ,vol. 70, pp. 183- 197 ,(1999) , 10.1093/AJCN.70.2.183
D. B. Calne, B. J. Snow, C. Lee, Criteria for diagnosing Parkinson's disease. Annals of Neurology. ,vol. 32, ,(1992) , 10.1002/ANA.410320721
M. J. Toth, P. S. Fishman, E. T. Poehlman, Free-living Daily Energy Expenditure in Patients with Parkinson's Disease Neurology. ,vol. 48, pp. 88- 91 ,(1997) , 10.1212/WNL.48.1.88
Ruth Hardoff, Michael Sula, Ada Tamir, Adrian Soil, Avi Front, Samich Badarna, Silvia Honigman, Nir Giladi, Gastric emptying time and gastric motility in patients with Parkinson's disease Movement Disorders. ,vol. 16, pp. 1041- 1047 ,(2001) , 10.1002/MDS.1203
S.M. Dobbs, R.J. Dobbs, C. Weller, A. Charlett, Link between Helicobacter pylori infection and idiopathic parkinsonism. Medical Hypotheses. ,vol. 55, pp. 93- 98 ,(2000) , 10.1054/MEHY.2000.1110
A. Charlett, R. J. Dobbs, A. G. Purkiss, D. J. Wrighe, D. W. Peterson, C. Weller, S. M. Dobbs, Cortisol is higher in parkinsonism and associated with gait deficit Acta Neurologica Scandinavica. ,vol. 97, pp. 77- 85 ,(2009) , 10.1111/J.1600-0404.1998.TB00614.X
M. Tonini, L. Cipollina, E. Poluzzi, F. Crema, G. R. Corazza, F. De Ponti, Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Alimentary Pharmacology & Therapeutics. ,vol. 19, pp. 379- 390 ,(2004) , 10.1111/J.1365-2036.2004.01867.X
Dobbs, Charlett, Dobbs, Weller, Peterson, Parkinsonism: differential age-trend in Helicobacter pylori antibody. Alimentary Pharmacology & Therapeutics. ,vol. 14, pp. 1199- 1205 ,(2000) , 10.1046/J.1365-2036.2000.00815.X